Cancer cells communicating with bone marrow cells

Melanoma's Sneaky Strategy: How Cancer Cells Manipulate Bone Marrow

Nico Varela monogram
Nico Varela in Health & Wellness October 2026 • 4 min read.

"Uncover the cunning ways melanoma cells influence bone marrow adipocytes, paving the path for metastasis. Learn how this cellular communication could lead to new cancer therapies."


Bone metastasis, the spread of cancer to the bones, remains a significant challenge in cancer treatment. While treatments exist, a definitive cure is still elusive for many. Recent research has illuminated the critical role of bone marrow adipocytes – specialized fat cells within the bone marrow – in supporting tumor growth and metastasis.

These adipocytes aren't just passive bystanders; they actively influence cancer cell behavior and metabolism. Understanding the intricate interplay between cancer cells and bone marrow adipocytes is crucial for unraveling the complexities of bone metastasis.

Now, a new study sheds light on how melanoma cells, a particularly aggressive form of skin cancer, manipulate bone marrow adipocytes to their advantage. By exploring this cellular conversation, researchers hope to identify new therapeutic targets to combat bone metastasis.

AI Search Multiple angles on this topic

Adipocytes in the Melanoma Niche

Bone marrow adipocytes increase in number and size during aging and obesity, prompting researchers to investigate whether they contribute to cancer initiation or progression within the marrow. In melanoma metastatic bone marrow niches, BM adipocytes rapidly increase and come into direct contact with metastasizing melanoma cells. These adipocytes can act as a tumor stromal population and may facilitate melanoma colonization and growth.

Tracing Bone Marrow Adipocyte Origins

Research has increasingly focused on the origin, biology, and regulation of bone marrow adipocytes. Lineage-tracing methods have provided evidence about the developmental origin of these cells, while adipose tissue and mesenchymal stem cells remain important research areas in bone marrow adiposity and hematopoiesis. Bone marrow adipose tissue continuously increases with age and obesity, conditions that direct mesenchymal lineages toward adipogenic cells.

The Art of Cellular Cross-Talk: How Melanoma Influences Bone Marrow

Cancer cells communicating with bone marrow cells

The study, published in the Journal of Visualized Experiments, details a meticulous approach to investigate the interaction between melanoma cells and bone marrow adipocytes. Researchers used a co-culture system, a classic and reliable method, to observe how these cells communicate.

This co-culture system involves growing bone marrow adipocytes and melanoma cells together in a controlled environment, allowing scientists to observe the effects of melanoma-derived factors on adipocyte differentiation – the process by which cells become specialized adipocytes.

  • Melanoma Cells Release Signals: Melanoma cells secrete various factors that can influence the behavior of nearby cells, including bone marrow adipocytes.
  • Adipocytes Respond: Bone marrow adipocytes respond to these signals, undergoing changes in their differentiation and function.
  • Dual Effects: The study reveals that melanoma-derived factors can have dual effects, both promoting and inhibiting adipocyte differentiation depending on the context.
AI Search Multiple angles on this topic

The Remodeling Marrow Environment

Bone marrow adipocytes are described as the most plentiful cells in bone marrow and as an endocrine organ that produces fatty acids, cytokines, and adipokines. Recent research characterizes bone marrow adipose tissue as a dynamic part of the marrow microenvironment that can influence tumor persistence, therapy response, and skeletal integrity. Reviews also describe BMAs as metabolic partners and stress-responsive components whose niche is remodeled by tumor progression and cancer therapy.

Evidence Remains Mixed

Research reviews have highlighted newly established roles for bone marrow adipose tissue in cancer progression and the possibility of targeting these cells therapeutically. However, the overall evidence remains mixed regarding how bone marrow adipose tissue and adipocytes affect cancer progression. More research is needed to determine how these microenvironmental cells contribute to malignancies in the marrow and which pathways might be clinically targetable.

The researchers found that tumor-derived factors initially promote the differentiation of bone marrow cells into adipocytes. However, as the tumor burden increases, this effect shifts, leading to a de-differentiation of the adipocytes. This means the mature adipocytes lose some of their specialized characteristics and potentially revert to a less mature state. An overload of melanoma cells can even cause necrosis, or cell death, in the adipocytes.

Implications for Cancer Treatment: Targeting the Bone Marrow Niche

This research highlights the dynamic and complex relationship between melanoma cells and bone marrow adipocytes. By manipulating the bone marrow microenvironment, melanoma cells create a niche that supports their survival and spread. Understanding these mechanisms could lead to new therapeutic strategies that target the bone marrow niche, disrupting the metastatic process and improving outcomes for cancer patients.

AI Search Multiple angles on this topic

Building Better Adipo-Oncology Models

Future adipo-oncology research is examining how bone marrow adipocytes may support bone metastasis and hematological malignancies through fatty acids, CXCL family chemokines, IL-6, and adipokines. A major frontier is improving the technical and biological methods used to study BM adipocytes in vitro and ex vivo. Some emerging approaches aim to mimic the in vivo microenvironment, reflecting challenges identified by the International Bone Marrow Adiposity Society's Biobanking Working Group.

Bone metastasis figures in context

  • 13% of melanoma patientsThe review reported bone metastases in 13% of melanoma patients; most diagnoses were confirmed by imaging.[1]

What the marrow findings suggest-and do not establish

In mice, a high-fat diet was linked to melanoma growth in bone marrow through a pathway involving marrow adipocytes and signaling molecules. Blocking either IL-6 or osteopontin reversed the reported growth and osteoclast effects, which points to those signals as contributors in that model, not proof of the same effect in people.[2]

Prior experiments also linked increased adipocyte differentiation to early marrow adipocyte increases and melanoma cell growth. Together, these findings describe a possible sequence in which changes in the marrow environment accompany tumor growth; they do not settle how adipocytes affect cancer onset or progression in bone.[3] [4]

How the evidence compares across settings

A separate review reported that marrow adipocytes expanded in tumor patients over a year, while noting that bone metastasis occurs preferentially in older people, who tend to have a higher proportion of these cells. This is human-context evidence, distinct from the controlled mouse comparison.[4]

Human marrow samples from different marrow cancers showed quantitative and morphological changes in adipocytes, but the reported work had few biopsies and lacked clinical and anthropometric correlations. Those constraints make it difficult to connect the observed cell changes to patient characteristics or outcomes.[5]

What remains unresolved about marrow adipocytes

  • Do adipocytes actively drive cancer onset or progression in bone, or do their changes mainly accompany tumor growth? The available review describes their precise influence as unresolved.[3]
  • How closely do adipocyte changes in human marrow cancers track with patients’ clinical and body measurements? The reported biopsy work could not make those correlations.[5]

Sources

  1. Incidence, Risk Factors, and Survival of Bone Metastases and Skeletal-Related Events in Melanoma Patients: A Systematic Review and Quality Assessment of 29 Studies (pmc.ncbi.nlm.nih.gov)
  2. High fat diet increases melanoma cell growth in the bone marrow by inducing osteopontin and interleukin 6 (pmc.ncbi.nlm.nih.gov)
  3. Role of bone marrow adipocytes in bone metastasis development and progression: a systematic review (pmc.ncbi.nlm.nih.gov)
  4. Distinct Metabolism of Bone Marrow Adipocytes and their Role in Bone Metastasis (pmc.ncbi.nlm.nih.gov)
  5. Morphological and Immunophenotypical Changes of Human Bone Marrow Adipocytes in Marrow Metastasis and Myelofibrosis (www.frontiersin.org)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

How do melanoma cells influence bone marrow to promote metastasis?

Melanoma cells manipulate bone marrow adipocytes by releasing various factors that initially promote their differentiation. However, as the tumor grows, these factors cause the adipocytes to de-differentiate, creating a supportive niche for melanoma survival and spread. This dynamic interaction is crucial for establishing bone metastasis. Further research is required to fully understand the complete signaling pathways involved and the specific factors responsible for each stage of adipocyte manipulation. Understanding these dynamics will facilitate the development of precisely targeted therapies.

2

What are bone marrow adipocytes, and why are they important in cancer research?

Bone marrow adipocytes are specialized fat cells within the bone marrow that actively influence cancer cell behavior and metabolism. They are crucial in cancer research because they are not just passive bystanders, but play a significant role in supporting tumor growth and metastasis, particularly in the context of bone metastasis. Understanding their interactions with cancer cells, like melanoma, can reveal new therapeutic targets. While this research focuses on melanoma, future investigations may explore the role of bone marrow adipocytes in other cancers that commonly metastasize to bone, such as breast and prostate cancer.

3

What is the co-culture system used in the study, and what does it reveal about melanoma and bone marrow adipocytes?

The co-culture system involves growing bone marrow adipocytes and melanoma cells together in a controlled environment. This setup allows researchers to observe the direct interaction and communication between these cells. The co-culture system reveals that melanoma cells secrete factors influencing adipocyte differentiation and function, demonstrating a complex cellular cross-talk that promotes metastasis. Although the co-culture system provides valuable insights, further in vivo studies are necessary to validate these findings in a more complex biological environment. This would involve observing the interaction between melanoma cells and bone marrow adipocytes within a living organism to confirm the mechanisms identified in vitro.

4

What are the potential implications of understanding how melanoma cells manipulate bone marrow adipocytes for cancer treatment?

Understanding the mechanisms by which melanoma cells manipulate bone marrow adipocytes can lead to new therapeutic strategies that target the bone marrow niche. By disrupting the metastatic process, these therapies could improve outcomes for cancer patients. Specifically, treatments could be developed to prevent the initial differentiation of adipocytes or to reverse the de-differentiation process caused by advanced tumors. These strategies could halt or slow down the formation of a supportive environment for melanoma metastasis in the bone marrow. Clinical trials will be essential to test the safety and efficacy of these new therapeutic approaches.

5

How do melanoma-derived factors exert dual effects on bone marrow adipocytes, and what does this mean for potential treatments?

Melanoma-derived factors initially promote the differentiation of bone marrow cells into adipocytes, but as the tumor burden increases, these factors lead to a de-differentiation of the adipocytes. This dual effect highlights the dynamic and complex relationship between melanoma cells and bone marrow adipocytes. For potential treatments, this means therapeutic strategies must consider the stage of tumor development. Early-stage interventions might focus on preventing initial adipocyte differentiation, while later-stage treatments might aim to restore adipocyte function and reverse de-differentiation. A more nuanced approach that accounts for these changing dynamics is essential for effective cancer treatment. Further research is required to identify specific biomarkers that indicate the stage of adipocyte manipulation, enabling personalized treatment strategies.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.